Halcyon Drugs And Formulation Private Limited - Company Profile

It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 2005.
2005 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Halcyon Drugs And Formulation Private Limited

Halcyon Drugs And Formulation Private Limited, a active private limited company, was established on 30 November 2005 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232UP2005PTC031018. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.80 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sujeet Sahu (Director), Rajesh Sahu (Director), Brijesh Kumar Sahu (Director). Past directors included Payal Sahu, Alka Shah, Uma Shankar Shah. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No. 102, Raman Villa Apartment 160-E Block, Shyam Nagar, Kanpur, Uttar Pradesh, 208013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UP2005PTC031018

  • Registration Number

    031018

  • Incorporation Date

    30 November 2005

  • Authorized Capital

    ₹0.80 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.80 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 20 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.50 M
  • Revenue Growth **** -12.47%
  • Profit Growth **** -60.30%
  • Ebitda **** -45.80%
  • Net Worth -1.05%
  • Total Assets **** 18.73%
Company report

Halcyon Drugs And Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Halcyon Drugs And Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Halcyon Drugs And Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Sujeet Sahu Director 30 Nov 2005 Current
Rajesh Sahu Director 01 Apr 2025 Current
Brijesh Kumar Sahu Director 01 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2013 Past
Pramod Abcsdd Director 13 Dec 2012 Past
Pramod Abcsdd Director 13 Dec 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Halcyon Drugs And Formulation.

Halcyon Drugs And Formulation Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 12.47% decrease. The company also saw a substantial fall in profitability, with a 60.3% decrease in profit. The company's net worth dipped by a decrease of 1.05%.

Halcyon Drugs And Formulation revenue growth over time
Halcyon Drugs And Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -12.47%
*******
*******
*******
*******
Revenue from Operations
*******
 -12.62%
*******
*******
*******
*******
Total Assets
*******
 18.73%
*******
*******
*******
*******
Profit or Loss
*******
 -60.30%
*******
*******
*******
*******
Net Worth
*******
 -1.05%
*******
*******
*******
*******
EBITDA
*******
 -45.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Halcyon Drugs And Formulation?

In 2017, Halcyon Drugs And Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,500,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
24 Jan 2009 Bank Of India ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Halcyon Drugs And Formulation?

Unlock and access historical data on people associated with Halcyon Drugs And Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Halcyon Drugs And Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halcyon Drugs And Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Halcyon Drugs And Formulation
Recent Activity within the Organization
  • Annual General Meeting

    The activity Halcyon Drugs And Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Rajesh Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 22 days . was recorded as a recent event.

  • Director Appointment

    Progress on Brijesh Kumar Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 22 days . was documented.

  • Balance Sheet

    Halcyon Drugs And Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.

  • Charges

    A charge registered on 24 Jan 2009 via Charge ID 10142349 with Bank Of India was fully satisfied on 23 May 2019. was recorded as a recent event.

  • Charges

    A charge with Bank Of India of Rs. 1.50 M registered on 24 Jan 2009 with Charge ID 10142349 was modified on 19 Aug 2010. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Halcyon Drugs And Formulation Private Limited?

The CIN of Halcyon Drugs And Formulation Private Limited is U24232UP2005PTC031018.

Where is Halcyon Drugs And Formulation Private Limited headquartered?

Halcyon Drugs And Formulation Private Limited is headquartered at Flat No. 102, Raman Villa Apartment 160-E Block, Shyam Nagar, Kanpur, Uttar Pradesh, 208013.

When was Halcyon Drugs And Formulation Private Limited incorporated?

Halcyon Drugs And Formulation Private Limited was incorporated on 30 November 2005.

Who are the current directors of Halcyon Drugs And Formulation Private Limited?

The current directors of Halcyon Drugs And Formulation Private Limited are

What is the primary industry of Halcyon Drugs And Formulation Private Limited?

The primary industry of Halcyon Drugs And Formulation Private Limited is Pharma.

Is Halcyon Drugs And Formulation Private Limited a listed company?

Halcyon Drugs And Formulation Private Limited is unlisted.

What is the capital structure of Halcyon Drugs And Formulation Private Limited?

The authorized capital of Halcyon Drugs And Formulation Private Limited is ₹0.80 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Halcyon Drugs And Formulation Private Limited?

The compliance status of Halcyon Drugs And Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available